Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

BACKGROUND: While surgery is the first-line treatment for patients with endogenous hypercortisolism (Cushing syndrome [CS]), mifepristone has been shown to be a beneficial medical treatment option, as demonstrated in the SEISMIC (Study of the Efficacy and Safety of Mifepristone in the Treatment of E...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Diabetes Endocrinol
Hlavní autoři: Brown, David R., East, Honey E., Eilerman, Bradley S., Gordon, Murray B., King, Elizabeth E., Knecht, Laura A., Salke, Brandon, Samson, Susan L., Yuen, Kevin C. J., Yau, Hanford
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596972/
https://ncbi.nlm.nih.gov/pubmed/33292727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40842-020-00105-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky